Possible involvement of opioid receptors in moclobemide-induced hypothermia in mice

Pharmacological Research

Volumn 48, Issue 3, 2003, Pages 237-240

  Ginawi, O T ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Hypothermia; MAO inhibition; Moclobemide; Naloxone; Opioid

Indexed keywords

ATROPINE; HALOPERIDOL; MEPYRAMINE MALEATE; METHYSERGIDE; MOCLOBEMIDE; NALOXONE; OPIATE ANTAGONIST; OPIATE RECEPTOR; PRAZOSIN; PROPANOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; HYPERTHERMIA; HYPOTHERMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; YEAST;

EID: 0038350999     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00108-7     Document Type: Article

References (20)

1. Da Prada M, Keller HH, Kettler R, Schaffner R, Pieri M, Burkard WP, et al. Ro 11-1163, a specific and short-acting MAO-inhibitor with antidepressant properties. In: Kamijo K, Usdin E, Nagatsu T, editors. Monoamine oxidase, basic and clinical frontiers. Amsterdam, Oxford, Princeton: Excerpta Medica; 1982. p. 321-7.
2. Da Prada M., Kettler R., Keller H.H., Burkard W.P. Short-lasting and reversible inhibition of monoamine oxidase-A by moclobemide. Acta Psychiatr. Scand. Suppl. 360:1990;103-105.
3. Haefely W., Barkard W.P., Ceusura A., Colzi A., Kettler R., Lorez H.P.et al. Pharmacology of moclobemide. Clin. Neuropharmacol. 16(Suppl. 2):1993;S8-18.
4. Gieschke R, Schmid-Burgk W. Interaction of moclobemide (Ro 11-1163) and oral tyramine (Basle lll). Roche research report no B-113886; 1987.
5. Korn A., Da Prada M., Raffesberg W., Gasic S. The effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressor effect of tyramine. J. Cardiovasc. Pharmacol. 11:1988;17-23.
6. Dingemanse J., Wood N., Guentert T., Oie S., Ouwerkerk M., Amrein R. Clinical pharmacology of moclobemide during chronic administration of high doses to healthy subjects. Psychopharmacology. 140:1998;164-172.
7. Lavian G., Finberg J.P., Youdim M.P. The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine. Clin. Neuropharmacol. 16(Suppl. 2):1993;S1-7.
8. Schlappi B. The lack of hepatotoxicity in the rat with the new and reversible MAO-A inhibitor moclobemide in contrast to iproniazid. Arzneim-Forsch/Drug Res. 35:1985;5800-5803.
9. Amrein R., Allen S.R., Vranesic D., Stabl M. Antidepressant drug therapy; associated risks. J. Neural Transm. 26(Suppl.):1988;73-86.
10. Pall M., Bested K.M., Eriksen N.D. Forgiftning med en reversibel og selektive monoaminoxydasehaemmer (Poisoning with a reversible and selective monoamine oxidase inhibitor). Ugeskr-Laeger. 159:1997;4859-4860.
11. Ulugol A., Karadag H.C., Dokmeci D., Al-Khatib I., Dokmeci I. The protective effect of moclobemide against hypoxia-induced lethality in mice is not due to a decrease in body temperature. Pharmacol. Biochem. Behav. 51:1995;245-247.
12. Gao B., Duncan W.C. Jr., Wehr T.A. Clorgyline-induced reduction in body temperature and its relationship to vigilance states in Syrian hamsters. Neuropsychopharmacology. 4:1991;187-197.
13. Adell A., Bigg T.A., Myers R.D. Action of harman (1-methyl-beta-carboline) on the brain: body temperature and in vivo efflux of 5-HT from hippocampus of the rat. Neuropharmacology. 35:1996;1101-1107.
14. Kest B., Alder M., Hopkins E. Sex differences in thermoregulation after acute and chronic morphine administration in mice. Neurosci. Lett. 291:2000;128-138.
15. Ageel A.M., Ginawi O.T. Effect of methamphetamine and methyldopa on ethanol induced hypothermia in mice. Japan J. Pharmacol. 37:1985;137-142.
16. Milanes M.V., Cremades A., Vargas M.L., Arnaldos J.D. Effect of selective monoamine oxidase inhibitors on the morphine-induced hypothermia in restrained rats. Gen. Pharmacol. 18:1987;185-188.
17. Cox B., Lomax P. Pharmacological studies on the central regulation of body temperature. Annu. Rev. Pharmacol. Toxicol. 17:1977;341-353.
18. Martin G.R., Humphrey P.P.A. Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology. 33:1994;261-273.
19. Cohen G., Kesler N. Monoamine oxidase inhibits mitochondrial respiration. Ann. N.Y. Acad. Sci. 893:1999;273-278.
20. Zamparelli M., Eaton S., Spitz L., Pierro A. Amino acids counteract the inhibitory effect of fentanyl on hepatocyte oxidative metabolism. J. Pediatr. Surg. 35:2000;736-739.